CN Patent

CN101155799A — 嘧啶化合物和使用方法

Assigned to TargeGen Inc · Expires 2008-04-02 · 18y expired

What this patent protects

本发明提供式(A)的嘧啶化合物。本发明的嘧啶化合物能够抑制激酶，例如Src激酶家族的成员，和各种其他特异性受体与非受体激酶。

USPTO Abstract

本发明提供式(A)的嘧啶化合物。本发明的嘧啶化合物能够抑制激酶，例如Src激酶家族的成员，和各种其他特异性受体与非受体激酶。

Drugs covered by this patent

Patent Metadata

Patent number
CN101155799A
Jurisdiction
CN
Classification
—
Expires
2008-04-02
Drug substance claim
No
Drug product claim
No
Assignee
TargeGen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.